Changes in Puffing Topography and Nicotine Consumption Depending on the Power Setting of Electronic Cigarettes.

What Was Tested

The paper reports a study of Therapeutic nicotine (patch, non-peptide), published as a randomized controlled trial.

The study purpose was to evaluate changes in puffing topography of experienced electronic cigarette users (vapers) when changing power settings in electronic cigarette battery devices.

Puff number and duration (mean [SD]) were recorded in the provided electronic cigarette battery device, whereas the atomizers were weighted before and after use to determine liquid and nicotine consumption.

Who Took Part

The age groups tagged for this paper are adults, both men and women.

Experienced adult vapers (n = 21) were recruited.

Participants used their own liquids and an atomizer and battery provided by the researchers.

How the Study Was Run

The design is described as randomized, single-blind and crossover.

The participants were allocated by chance, so the Therapeutic nicotine (patch, non-peptide) group and the comparison group should start out alike.

In this single-blind Therapeutic nicotine (patch, non-peptide) study one party knew the assignments and the other did not.

Each person switched between Therapeutic nicotine (patch, non-peptide) and the comparison at some point, usually with a gap in between.

Two 30-minute sessions were performed, with the device power set at 6 W and 10 W, in a randomized, crossover, participant-blinded design.

What Was Measured

PubMed files the paper under topics including Electronic Nicotine Delivery Systems, Nicotine, Smokers and Vaping.

What This Means in Plain Language

The paper is a randomized, single-blind and crossover study of Therapeutic nicotine (patch, non-peptide).

Its findings take up roughly 9 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2018 (Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco), a journal based in England.

More context: the Therapeutic nicotine (patch, non-peptide) compound page, all human trials.